A Comparison of Polysomnographic Variables Between Adolescents with Polycystic Ovarian Syndrome with and without the Metabolic Syndrome
- 1 June 2011
- journal article
- research article
- Published by Mary Ann Liebert Inc in Metabolic Syndrome and Related Disorders
- Vol. 9 (3), 191-196
- https://doi.org/10.1089/met.2010.0081
Abstract
Background: We aimed to determine the differences in polysomnographic variables between obese adolescents with polycystic ovarian syndrome (PCOS) with and without metabolic syndrome, as the prevalence of obstructive sleep apnea syndrome (OSAS) is increased in adults with PCOS, OSAS has been regarded as a manifestation of the metabolic syndrome, and the prevalence of metabolic syndrome is increased in patients with PCOS. Methods: Fourteen obese adolescents with PCOS and metabolic syndrome [15.7 years ± 1.9, body mass index (BMI) 36.2 kg/m2 ± 6.2], 14 obese adolescents with PCOS without metabolic syndrome (15.7 years ± 1.1, BMI 33.8 kg/m2 ± 6.2), 19 healthy, obese adolescents without PCOS or metabolic syndrome (15.3 years ± 1.0, BMI 34.4 kg/m2 ± 6.5), and 14 healthy, normal-weight adolescents (15.4 years ± 0.7, BMI 21.1 kg/m2 ± 2.2) underwent polysomnography to compare transcutaneous arterial oxygen saturation (Sat O2), apnea index (AI), hypopnea index (HI), apnea–hypopnea index (AHI), the absolute number of obstructive apneas (NOA), percentage sleep stages 3 and 4 of non REM-sleep (stages 3 and 4), percentage of rapid eye movement (REM) sleep (%REM), sleep-onset latency, and sleep efficiency. Results: We found no differences among the four groups concerning AI, HI, AHI, NOA, and stages 3 and 4. Significant differences among the groups were found regarding Sat O2 (P = 0.04), %REM (P = 0.03), sleep-onset latency (P = 0.002), and sleep efficiency (P = 0.01). Conclusions: Weight status, PCOS, and metabolic syndrome do not seem to have significant effects on respiratory polysomnographic variables in adolescent girls with PCOS, suggesting that the pathomechanisms leading to OSAS in patients with PCOS develop in the later course of the disease.Keywords
This publication has 35 references indexed in Scilit:
- Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2008
- Practice patterns of screening for sleep apnea in physicians treating PCOS patientsSleep and Breathing, 2007
- Relationships between Sleep Disordered Breathing and Glucose Metabolism in Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2006
- Obstructive Sleep Apnea as a Risk Factor for Stroke and DeathNew England Journal of Medicine, 2005
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- Polycystic ovary syndrome: Syndrome XX?Trends in Endocrinology & Metabolism, 2003
- The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndromeSleep Medicine, 2002
- Increased Prevalence of Obstructive Sleep Apnea Syndrome in Obese Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2001
- Polycystic Ovary Syndrome Is Associated with Obstructive Sleep Apnea and Daytime Sleepiness: Role of Insulin ResistanceJournal of Clinical Endocrinology & Metabolism, 2001
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective StudyJournal of Clinical Endocrinology & Metabolism, 1998